BioSpace News Archive

Pharm Country

Taglich Brothers Initiates Coverage of First Choice Healthcare Solutions, Inc.

Taglich Brothers, Inc. announces that it has initiated coverage of First Choice Healthcare Solutions, Inc.

July 5, 2018
·
2 min read
Business

MNG Laboratories, Pronto Diagnostics Partner to Offer Clinical RNA Sequencing Services in Israel

MNG Laboratories is pleased to announce that it has signed a Distribution Agreement with Pronto Diagnostics, a leading Israeli genomics company, to exclusively market its complete line of Clinical RNA Sequencing Services in Israel.

July 5, 2018
·
3 min read
Policy

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Flex Pharma, Inc.

Federman & Sherwood announces that on June 19, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Flex Pharma, Inc.

July 5, 2018
·
1 min read
Lexington Biosciences Concludes Initial HeartSentry Clinical Study--Company prepares for multicenter pivotal clinical study

Lexington Biosciences, Inc. is pleased to announce the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research.

July 5, 2018
·
5 min read
Deals

RENNOVA HEALTH ANNOUNCES CONFIRMATION FROM TENNESSEE DEPARTMENT OF HEALTH THAT A NEW LICENSE NUMBER HAS BEEN ISSUED DUE TO THE CHANGE OF OWNERSHIP FOR JAMESTOWN TN, MEDICAL CENTER.

Rennova Health, Inc. announces that it has received confirmation from the Tennessee Department of Health that they have completed the change of ownership (CHOW) process and issued a license number to Jamestown TN Medical Center, Inc.

July 5, 2018
·
3 min read
BioMidwest

BRACAnalysis® CDx Identifies Patients Who Respond to Lynparza® in SOLO-1 Study

Myriad Genetics, Inc. announced that the Company’s BRACAnalysis® CDx test identified responders to Lynparza®

July 5, 2018
·
6 min read
Drug Development

ProQR Initiates Phase 1/2 Clinical Trial of QR-313 for Dystrophic Epidermolysis Bullosa

The trial, called WINGS, will evaluate the safety and efficacy of QR-313 in subjects with recessive dystrophic epidermolysis bullosa due to mutations in exon 73 of the COL7A1 gene.

July 5, 2018
·
6 min read
FDA

Rafael Pharmaceuticals Receives FDA Orphan Drug Designation for Treatment of Burkitt Lymphoma, and Initiates a Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia

Rafael Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CPI-613

July 5, 2018
·
4 min read
Business

RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

RedHill has been grantedthe exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release tablets) in the U.S. to certain gastroenterologists and primary care physicians for the approved indication in people living with HIV/AIDS by Napo Pharmaceuticals, a subsidiary of Jaguar Health

July 5, 2018
·
10 min read
Business

Mount Tam Biotechnologies Announces Appointment of New Member to the Board of Directors

Mount Tam Biotechnologies, Inc. is pleased to announce that James Farrell has joined its Board of Directors.

July 5, 2018
·
4 min read